Oncogenic inflammation and autoimmune disease

Autoimmunity Reviews

Volumn 6, Issue 2, 2006, Pages 107-114

  Eisenlohr, Laurence C ^a   Rothstein, Jay L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cytokines; Fusion protein; Inflammation; Oncogene; T cells; Tyrosine kinases

Indexed keywords

ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CARCINOGENICITY; CELL TRANSFORMATION; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; LYMPHOCYTE ACTIVATION; NONHUMAN; REVIEW; STIMULATION; TARGET ORGAN;

ANIMALS; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASES; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; INFLAMMATION; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; NEOPLASMS;

EID: 33751320904     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.04.002     Document Type: Review

References (41)

1. Silink M. Childhood diabetes: a global perspective. Horm Res 57 Suppl 1 (2002) 1-5
2. Jacobson D.L., Gange S.J., Rose N.R., and Graham N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84 (1997) 223-243
3. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
4. Ohashi P.S., Oehen S., Buerki K., Pircher H., Ohashi C.T., Odermatt B., et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65 (1991) 305-317
5. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., et al. Positional cloning of the APECED gene. Nat Genet 17 (1997) 393-398
6. Weetman A.P. Determinants of autoimmune thyroid disease. Nat Immunol 2 (2001) 769-770
7. Swallow M.M., Wallin J.J., and Sha W.C. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity 11 (1999) 423-432
8. Ndhlovu L.C., Ishii N., Murata K., Sato T., and Sugamura K. Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis. J Immunol 167 (2001) 2991-2999
9. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 12 (1994) 991-1045
10. Rock K.L., Hearn A., Chen C.J., and Shi Y. Natural endogenous adjuvants. Springer Semin Immunopathol (2004)
11. Miller C.G., Shchelkunov S.N., and Kotwal G.J. The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein. Virology 229 (1997) 126-133
12. McFarlane B.M., Bridger C., Tibbs C.J., Saleh M.G., Fuzio A., Verucchi G., et al. Virus-induced autoimmunity in hepatitis C virus infections: a rare event. J Med Virol 42 (1994) 66-72
13. Garza K.M., Chan V.S., and Ohashi P.S. T cell tolerance and autoimmunity. Rev Immunogenet 2 (2000) 2-17
14. Stanzani M., Martins S.L., Saliba R.M., St John L.S., Bryan S., Couriel D., et al. CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans. Blood 103 (2004) 1140-1146
15. O'Garra A., and Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 10 (2004) 801-805
16. McKnight A.J., Perez V.L., Shea C.M., Gray G.S., and Abbas A.K. Costimulator dependence of lymphokine secretion by naive and activated CD4+ T lymphocytes from TCR transgenic mice. J Immunol 152 (1994) 5220-5225
17. Ridge J.P., Di Rosa F., and Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell [see comments]. Nature 393 (1998) 474-478
18. O'Keefe J.P., Blaine K., Alegre M.L., and Gajewski T.F. Formation of a central supramolecular activation cluster is not required for activation of naive CD8+ T cells. Proc Natl Acad Sci U S A 101 (2004) 9351-9356
19. Vezys V., and Lefrancois L. Cutting edge: inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J Immunol 169 (2002) 6677-6680
20. Panayi G.S., Corrigall V.M., and Henderson B. Stress cytokines: pivotal proteins in immune regulatory networks; opinion. Curr Opin Immunol 16 (2004) 531-534
21. Russell J.P., Engiles J.B., and Rothstein J.L. Proinflammatory mediators and genetic background in oncogene mediated tumor progression. J Immunol 172 (2004) 4059-4067
22. Wirtschafter A., Schmidt R., Rosen D., Kundu N., Santoro M., Fusco A., et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope 107 (1997) 95-100
23. Sheils O.M., O'Leary J.J., Uhlmann V., Luttich K., and Sweeney E.C. ret/PTC-1 activation in Hashimoto's thyroiditis. Int J Surg Pathol 8 (2000) 185-189
24. Hwang E.S., Kim D.W., Hwang J.H., Jung H.S., Suh J.M., Park Y.J., et al. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases. Mol Endocrinol 18 (2004) 2672-2684
25. Hunt J.L., Baloch Z.W., Barnes L., Swalsky P.A., Trusky C.L., Sesatomi E., et al. Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis. Endocr Pathol 13 (2002) 321-330
26. Loh K.C., Greenspan F.S., Dong F., Miller T.R., and Yeo P.P. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84 (1999) 458-463
27. Jackson E.L., Willis N., Mercer K., Bronson R.T., Crowley D., Montoya R., et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15 (2001) 3243-3248
28. Ji H., Houghton A.M., Mariani T.J., Perera S., Kim C.B., Padera R., et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene 25 (2006) 2105-2112
29. Speirs K., Lieberman L., Caamano J., Hunter C.A., and Scott P. Cutting edge: NFkappa B2 is a negative regulator of dendritic cell function. J Immunol 172 (2004) 752-756
30. Heath W.R., and Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19 (2001) 47-64
31. Rosenberg S.A., Yang J.C., and Restifo N.P. Cancer immunotherapy: moving beyond current vaccines. Nat Med 10 (2004) 909-915
32. Chiovato L., Latrofa F., Braverman L.E., Pacini F., Capezzone M., Masserini L., et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 139 (2003) 346-351
33. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., and Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 284 (1999) 825-829
34. Caturegli P., Hejazi M., Suzuki K., Dohan O., Carrasco N., Kohn L.D., et al. Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid. Proc Natl Acad Sci U S A 97 (2000) 1719-1724
35. Frohman M., Francfort J.W., and Cowing C. T-dependent destruction of thyroid isografts exposed to IFN-gamma. J Immunol 146 (1991) 2227-2234
36. Giordano C., Stassi G., De Maria R., Todaro M., Richiusa P., Papoff G., et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis [see comments]. Science 275 (1997) 960-963
37. Greten F.R., and Karin M. The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer. Cancer Lett 206 (2004) 193-199
38. McCulloch J., Lydyard P.M., and Rook G.A. Rheumatoid arthritis: how well do the theories fit the evidence?. Clin Exp Immunol 92 (1993) 1-6
39. Leng Q., and Bentwich Z. Beyond self and nonself: fuzzy recognition of the immune system. Scand J Immunol 56 (2002) 224-232
40. Abraham E.J., Kodama S., Lin J.C., Ubeda M., Faustman D.L., and Habener J.F. Human pancreatic islet-derived progenitor cell engraftment in immunocompetent mice. Am J Pathol 164 (2004) 817-830
41. Rhoden KJ, Unger K, Salvatore LG, Yilmaz V, Vovk V, Chiappetta G, et al. RET/PTC rearrangement in non-neoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab in press.